Patent · US Active

Intracutaneous injection

US8110209B2 · kind B2 · utility

94Cited by
21References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 22, 2003
Grant dateFeb 7, 2012
Priority date
Expiry dateSep 29, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2205/59
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The delivery of biopharmaceutical and other therapeutic agents parenterally to an animal via a minimally invasive, low pain administration is provided. The agents are delivered to the patient via, e.g., the epidermal, dermal, or subcutaneous layer of the skin in a concentrated form of injectable paste of slurry.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.